Table 1 Occurrence of complications of glucocorticoid therapy in patients with Graves’ orbitopathy (based on Marcocci et al., 2001 [9])
Oral (n = 27) | Intravenous (n = 41) | |
|---|---|---|
Mild to moderate: | ||
Hyperglycemia, gain in body weight, depression, and Cushingoid features | 17 | 27 |
Severe: | ||
Cardiovascular, cerebrovascular, > 4-fold increase in liver enzymes, acute liver failure, autoimmune hepatitis | 10 | 14 |